Page last updated: 2024-12-06

tipindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tipindole is a synthetically produced indole alkaloid that exhibits a wide range of pharmacological activities, including anti-inflammatory, antioxidant, and anticancer properties. It is a potent inhibitor of the enzyme indoleamine 2,3-dioxygenase (IDO), which is involved in the immune response and tumor growth. Tipindole has been shown to have potential therapeutic benefits in the treatment of various diseases, including cancer, inflammation, and autoimmune disorders. Its unique structure and biological activity have made it a subject of ongoing research to explore its full therapeutic potential.'

tipindole: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65595
CHEMBL ID494521
SCHEMBL ID2108871
MeSH IDM0061701

Synonyms (33)

Synonym
HMS1473G01
smr000339596
MLS000766700 ,
2-(dimethylamino)ethyl 1,3,4,5-tetrahydrothiopyrano[4,3-b]indole-8-carboxylate
OPREA1_217221
CBDIVE_003274
IDI1_019451
CHEMDIV3_000133
OPREA1_634118
tipindole
AKOS001582675
2-(dimethylamino)ethyl 1h,3h,4h,5h-thiopyrano[4,3-b]indole-8-carboxylate
CHEMBL494521
mfcd00868055
tipindolum [inn-latin]
tipindol
tipindole [inn]
tipindol [inn-spanish]
us65h9wbnh ,
2-(dimethylamino)ethyl 1,3,4,5-tetrahydrothiopyrano(4,3-b)indole-8-carboxylate
tipindolum
7489-66-9
1,3,4,5-tetrahydrothiopyrano(4,3-b)indole-8-carboxylic acid, 2-(dimethylamino)ethyl ester
unii-us65h9wbnh
CCG-103021
1,3,4,5-tetrahydrothiopyrano[4,3-b]indole-8-carboxylic acid 2-(dimethylamino)ethyl ester;hydrochloride
bdbm78798
1,3,4,5-tetrahydrothiopyran[4,3-b]indole-8-carboxylic acid 2-(dimethylamino)ethyl ester;hydrochloride
2-(dimethylamino)ethyl 1,3,4,5-tetrahydrothiopyrano[4,3-b]indole-8-carboxylate;hydrochloride
cid_2831581
DTXSID70225869
SCHEMBL2108871
Q27291237
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID390734Cytotoxicity against african green monkey BSC1 cells after 20 hrs WST-1 based assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID390731Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID390732Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as reduction in plaque formation after 20 hrs2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.85 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]